文献速递儿童心血管与肾脏儿童内分泌与遗传代谢儿童消化与营养

动脉粥样硬化性心血管风险成为儿科新优先事项

Atherosclerotic Cardiovascular Risk as an Emerging Priority in Pediatrics.
PubMed 文献 · Pediatrics · 2022-01-01

儿童和青少年期是预防日后动脉粥样硬化性心血管疾病(ASCVD)的重要窗口。综述指出,动脉粥样硬化始于童年,肥胖、高血压、高脂血症和高血糖可加速其发展;多种儿科疾病(如慢性炎症性疾病、移植受者、家族性高胆固醇血症等)的ASCVD风险与肥胖相似甚至更高。心血管风险管理已进入普通儿科领域。

要点

  • 动脉粥样硬化始于儿童期,肥胖儿童日后ASCVD死亡相对风险约2.5。
  • 多种儿科疾病(如慢性炎症、移植、家族性高胆固醇血症)ASCVD风险不低于肥胖。
  • 早期预防可改善长期心血管结局,心血管风险管理应纳入普通儿科实践。

核心结论

  • 儿童和青少年期是预防动脉粥样硬化性心血管疾病(ASCVD)的重要窗口,早期预防可改善长期心血管结局。

研究设计与样本

  • 本文为综述,讨论动脉粥样硬化早期发展的研究进展及儿科疾病相关风险因素。

主要发现

  • 非人灵长类研究和人类尸检研究显示,动脉粥样硬化始于儿童期,最初发生于髂动脉和腹主动脉,随后累及动脉树更高部位。
  • 儿童和青少年期肥胖、高血压、高脂血症和高血糖可加速动脉粥样硬化形成。
  • 与正常体重同龄人相比,肥胖儿童和青少年日后ASCVD死亡的相对风险约为2.5。
  • 多种儿科疾病(如慢性炎症性疾病、器官移植受者、家族性高胆固醇血症、内分泌疾病、儿童癌症幸存者、慢性肾脏病、先天性心脏病和早产尤其是胎儿生长受限后)的ASCVD风险与肥胖相似甚至更高。

临床怎么用

  • 儿科医生应认识到儿童期是ASCVD预防的关键窗口,对肥胖及上述高危疾病患儿进行心血管风险管理。

局限性

  • 本文为综述,未报告原始研究的具体样本量、置信区间或P值等数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Over the last decades, childhood and adolescence have emerged as an important window of opportunity to prevent atherosclerotic cardiovascular disease (ASCVD) later in life. Here, we discuss the underlying advances in the field. First, atherosclerosis development starts as early as childhood. Atherogenesis initiates in the iliac arteries and abdominal aorta and subsequently develops in higher regions of the arterial tree, as has been demonstrated in nonhuman primate studies and human autopsy studies. Obesity, hypertension, hyperlipidemia, and hyperglycemia at a young age can accelerate atherogenesis. Children and adolescents with obesity have a relative risk of ∼ 2.5 for ASCVD mortality later in life, compared to peers with a normal weight. Conversely, early prevention improves long-term cardiovascular outcomes. Second, we review disease-associated factors that add to the traditional risk factors. Various pediatric disorders carry similar or even higher risks of ASCVD than obesity, including chronic inflammatory disorders, organ transplant recipients, familial hypercholesterolemia, endocrine disorders, childhood cancer survivors, chronic kidney diseases, congenital heart diseases, and premature birth, especially after fetal growth restriction. The involved disease-associated factors that fuel atherogenesis are diverse and include inflammation, vascular, and endothelial factors. The diverse and growing list of pediatric groups at risk underscores that cardiovascular risk management has solidly entered the realm of general pediatrics. In a second review in this series, we will, therefore, focus on recent advances in cardiovascular risk assessment and management and their implications for pediatric practice.

来源:Pediatrics,查看原文。版权归原作者所有。

引用

  1. Schipper HS, de Ferranti S. Atherosclerotic Cardiovascular Risk as an Emerging Priority in Pediatrics. Pediatrics. 2022. PMID: 36217888. doi:10.1542/peds.2022-057956

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。